EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of the Inflammatory Burden Index With Increased Mortality Among Cancer Patients: Insights From the NHANES Study

Xiuxiu Qiu iD, Yiyi Zhang, Yingjie Zhu, Ming Yang, Li Tao iD

Immunity, Inflammation and Disease · 2024-12 · 12 (12)

DOI: 10.1002/iid3.70067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 06.12.2024. Verfasst von Xiuxiu Qiu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Neoplasms, Nutrition Surveys, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The research was supported by the Shanghai Clinical Medical Research Center of Traditional Chinese Medicine Oncology/the Science and Technology Commission of S….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The systemic inflammatory response significantly influences the progression and prognosis of various cancers. The novel Inflammatory Burden Index (IBI) was recently introduced as a biomarker to gauge systemic inflammation and evaluate cancer patient prognosis. However, studies investigating the relationship between IBI and mortality rates in cancer patients remain limited.

Methods

This study analyzed data from 2748 cancer patients enrolled in the National Health and Nutrition Examination Surveys between 1999 and 2018. We used weighted Cox regression analysis and restricted cubic spline models to examine the relationship between the IBI and mortality due to all causes, cardiovascular disease (CVD), and cancer. Furthermore, we employed Kaplan‐Meier survival curves, subgroup analyses, and receiver operating characteristic curves to elaborate on these associations.

Results

Over a median follow‐up period of 112 months, the cohort experienced 1067 deaths, including 320 from cancer, 239 attributable to heart disease, and 508 from various other causes. The Kaplan‐Meier curve indicated that individuals in the higher quartiles of the IBI faced significantly increased mortality risks compared to those in lower quartiles. Analyses using weighted Cox proportional hazards models demonstrated that subjects in the top IBI quartile were at a substantially higher risk for all‐cause mortality (Hazard Ratio [HR] 2.09, 95% Confidence Interval [CI] 1.67–2.62, p < 0.001), CVD mortality (HR = 1.95, 95% CI= 1.18–3.23, p = 0.010), and cancer mortality (HR = 2.06, 95% CI = 1.31–3.26, p = 0.002). Furthermore, stratification and interaction analyses affirmed the uniformity of these initial findings. The areas under the curve for the 3‐, 5‐, and 10‐year survival predictions for all‐cause mortality were 0.62, 0.62, and 0.67, respectively; for cardiovascular mortality, they were 0.64, 0.64, and 0.70; and for cancer mortality, they were 0.62, 0.77, and 0.70.

Conclusion

In cancer patients, higher IBI levels significantly correlate with increased mortality from all causes, CVD, and cancer‐specific deaths. This index could possess considerable diagnostic and prognostic importance, possibly acting as a new biomarker for evaluating outcomes in cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNutrition SurveysInflammationHumansMaleFemaleMiddle AgedPrognosisAgedCardiovascular DiseasesAdultBiomarkersProportional Hazards ModelsUnited StatesRisk FactorsKaplan-Meier Estimate

Stichwörter der Autor:innen

NHANEScancer patientscardiovascular disease mortalityinflammatory burden indexmortality rates

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Intensive Care Unit, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Good Clinical Practice, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID-Profile: Xiuxiu Qiu, Li Tao

Förderung

  • The research was supported by the Shanghai Clinical Medical Research Center of Traditional Chinese Medicine Oncology/the Science and Technology Commission of S…

Zitieren

APA

Qiu, X., Zhang, Y., Zhu, Y., Yang, M., & Tao, L. (2024). Association of the Inflammatory Burden Index With Increased Mortality Among Cancer Patients: Insights From the NHANES Study. Immunity, Inflammation and Disease, 12(12). https://doi.org/10.1002/iid3.70067

Vancouver

Qiu X, Zhang Y, Zhu Y, Yang M, Tao L. Association of the Inflammatory Burden Index With Increased Mortality Among Cancer Patients: Insights From the NHANES Study. Immunity, Inflammation and Disease. 2024;12(12). doi:10.1002/iid3.70067

BibTeX
@article{Qiu2024,
  author = {Qiu, Xiuxiu and Zhang, Yiyi and Zhu, Yingjie and Yang, Ming and Tao, Li},
  title = {Association of the Inflammatory Burden Index With Increased Mortality Among Cancer Patients: Insights From the NHANES Study},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  volume = {12},
  number = {12},
  doi = {10.1002/iid3.70067}
}
Kostenlos starten →